Status:
COMPLETED
Remote Ischemic Preconditioning in ad Hoc Percutaneous Coronary Interventions
Lead Sponsor:
Cardiovascular Research Society, Greece
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Elective percutaneous coronary intervention (PCI) is associated with troponin release in approximately one third of cases. Myocardial necrosis may result from downstream embolization of atheromatous m...
Detailed Description
Elective percutaneous coronary intervention (PCI) is associated with troponin release in approximately one third of cases, which is a sensitive and specific marker of myocyte necrosis. Myocardial necr...
Eligibility Criteria
Inclusion
- Patients with a significant stenosis as documented in coronary angiography eligible for PCI
- Patients ≥ 18 of age and able to give informed consent
Exclusion
- Severe comorbidity (estimated life expectancy \<6 months)
- Use of nicorandil or glibenclamide
- Elevated baseline cTnI before PCI
- Renal disease as documented by serum creatinine before PCI
- LVEF\<35%
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT01158716
Start Date
July 1 2011
End Date
June 1 2012
Last Update
April 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Athens Euroclinic
Athens, Attica, Greece, 11521